Evidence map›Paper›PMID 30878628›Full record

ArticleAnnals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology2019

Challenges and safety of beta-lactam desensitization during extracorporeal membrane oxygenation.

Dinah Foer, Kathleen Marquis, Natasha Romero, Mariana C Castells

Abstract readCase ReportsLetter
In one paragraph

Article in Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Dinah FoerBrigham and Women's Hospital, Boston, Massachusetts; Drug Hypersensitivity and Desensitization Center at Brigham and Women's Hospital, Boston, Massachusetts. Electronic address: dfoer@bwh.harvard.edu.
Kathleen MarquisBrigham and Women's Hospital, Boston, Massachusetts; Drug Hypersensitivity and Desensitization Center at Brigham and Women's Hospital, Boston, Massachusetts.
Natasha RomeroBrigham and Women's Hospital, Boston, Massachusetts.
Mariana C CastellsBrigham and Women's Hospital, Boston, Massachusetts; Drug Hypersensitivity and Desensitization Center at Brigham and Women's Hospital, Boston, Massachusetts.

Funding

IMMUNOLOGIC BASIS OF RESISTANCE AND HYPERSENSITIVITYT32AI007306 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI Nora Amanda Barrett, Joshua A Boyce · 1985 to 2026
$12.2M
NIAID NIH HHS T32 AI007306
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AcetatesAllergensAnaphylaxisAntibiotic ProphylaxisAnti-Infective Agentsbeta-LactamsCetirizineCyclopropanesCystic FibrosisDesensitization, ImmunologicDrug HypersensitivityExtracorporeal Membrane OxygenationFamotidineFemaleHumansImmune ToleranceAcetatesAllergensAnti-Infective Agentsbeta-LactamsCetirizineCyclopropanesFamotidinemontelukastQuinolinesSulfides

Identifiers

PMID30878628
PMCPMC6555662

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.